Skip to search formSkip to main contentSkip to account menu

ufibrate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The toxicological characteristic of a new ukrainian hypolipidemic drug ufibrate
1997
1997
[The antidyslipoproteinemic activity of ufibrate in patients with non-insulin-dependent diabetes mellitus].
Ufibrate (150 mg daily) was found to have a beneficial effect on main parameters characterizing lipid metabolism, with no effect… 
1997
1997
[The antidyslipoproteinemic activity of ufibrate in patients with non-insulin-dependent diabetes mellitus].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)